Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.19 USD | +5.18% | -0.77% | +148.45% |
04-11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
04-03 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+148.45% | 324M | |
+10.44% | 107B | |
+0.82% | 106B | |
+9.05% | 23.47B | |
-13.89% | 21.9B | |
-6.03% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Baird Downgrades Homology Medicines to Neutral From Outperform, Adjusts Price Target to $1.50 From $9